ImageneBio Inc
IMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $4 | $5 |
| Gross Profit | $0 | -$0 | -$4 | -$5 |
| % Margin | – | – | – | – |
| R&D Expenses | $16 | $4 | $4 | $5 |
| G&A Expenses | $11 | $4 | $6 | $8 |
| SG&A Expenses | $11 | $4 | $6 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$2 | -$4 |
| Operating Expenses | $27 | $9 | $7 | $8 |
| Operating Income | -$27 | -$9 | -$11 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | $6 | $2 | $3 |
| Pre-Tax Income | -$25 | -$3 | -$9 | -$9 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$25 | -$3 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS | -3.005 | -0.057 | -0.18 | -0.19 |
| % Growth | -5,144.7% | 68.2% | 5.3% | – |
| EPS Diluted | -3.005 | -0.057 | -0.18 | -0.19 |
| Weighted Avg Shares Out | 9 | 48 | 48 | 48 |
| Weighted Avg Shares Out Dil | 9 | 48 | 48 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$25 | -$8 | -$9 | -$12 |
| % Margin | – | – | – | – |